Qlife Holding Past Earnings Performance

Past criteria checks 0/6

Qlife Holding's earnings have been declining at an average annual rate of -41%, while the Medical Equipment industry saw earnings growing at 22.9% annually. Revenues have been declining at an average rate of 32.4% per year.

Key information

-41.0%

Earnings growth rate

5.7%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate-32.4%
Return on equity-80,885.9%
Net Margin-233,279.7%
Next Earnings Update12 Feb 2025

Recent past performance updates

Recent updates

Shareholders May Be A Bit More Conservative With Qlife Holding AB (publ)'s (STO:QLIFE) CEO Compensation For Now

Jun 19
Shareholders May Be A Bit More Conservative With Qlife Holding AB (publ)'s (STO:QLIFE) CEO Compensation For Now

Is Qlife Holding (STO:QLIFE) A Risky Investment?

Aug 05
Is Qlife Holding (STO:QLIFE) A Risky Investment?

Is Qlife Holding (STO:QLIFE) A Risky Investment?

Feb 23
Is Qlife Holding (STO:QLIFE) A Risky Investment?

Revenue & Expenses Breakdown

How Qlife Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:QLIFE Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-16144-4
30 Jun 240-14240-8
31 Mar 240-15252-13
31 Dec 230-16059-21
30 Sep 231-8572-26
30 Jun 233-9791-36
31 Mar 237-95103-44
31 Dec 2218-93114-47
30 Sep 2229-69111-45
30 Jun 2233-62105-38
31 Mar 2265-6092-5
31 Dec 2140-3980-26
30 Sep 2148-3380-18
30 Jun 2151-2372-11
31 Mar 2151-1564-5
31 Dec 2043-20550
30 Sep 2025-37440
30 Jun 2021-37360
31 Mar 2013-38290
31 Dec 1912-32250

Quality Earnings: QLIFE is currently unprofitable.

Growing Profit Margin: QLIFE is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: QLIFE is unprofitable, and losses have increased over the past 5 years at a rate of 41% per year.

Accelerating Growth: Unable to compare QLIFE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: QLIFE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (31%).


Return on Equity

High ROE: QLIFE has a negative Return on Equity (-80885.93%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 02:17
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Qlife Holding AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carl RamaniusRedeye